PGEN stock news
This page provides real-time market news, earnings updates, and company announcements related to Precigen, Inc. (PGEN).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-09 22:19 EST

Precigen, Inc. (PGEN) Builds Commercial Stage With Global Regulatory Support
Finviz2026-02-13 12:18:44
Foghorn Therapeutics Inc. (FHTX) Posts Fourth Quarter Loss, Surpasses Revenue Projections
101 finance2026-03-11 22:58:03
Precision BioSciences (DTIL) Exceeds Expectations for Q4 Earnings and Revenue
101 finance2026-03-12 13:18:49

Precigen Reports Full Year 2025 Financial Results and Business Updates
Finviz2026-03-25 20:06:49
Precigen, Inc. (PGEN) Posts Fourth Quarter Loss, Misses Revenue Expectations
101 finance2026-03-25 22:42:50

Precigen Jumps 28% During the Day: Is This a Biotech Rally or a Risky Move?
101 finance2026-03-26 14:48:58

Precigen's $430M Burn vs $18M Q1 Bet: Why Wall Street's $8.50 Target Risks a Reality Check
101 finance2026-03-27 00:30:53

Precigen’s Platform Gains Exponential Traction as Gene Therapy Adoption Infrastructure Takes Hold
101 finance2026-03-27 12:27:40

Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31
Finviz2026-03-30 12:33:38

Precigen Surges 11% in Dramatic Intraday Rally: What's Fueling the Momentum?
101 finance2026-03-31 16:34:17

Precigen Drops 8.19% as Market Sends Mixed Messages and Technical Indicators Turn Bearish
101 finance2026-04-01 00:18:46

Precigen’s PAPZIMEOS: S-Curve Uptake Accelerates as Barriers Diminish
101 finance2026-04-01 05:57:45

PGEN Soars 18% But Bearish Tech Signals Warn of Volatility
101 finance2026-04-02 00:43:13

Precigen's Revenue Beat Already Priced In, But Burn Rate Risks Remain Unseen
101 finance2026-04-06 02:54:54

Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million
Finviz2026-04-07 11:03:42
Precigen, Inc. (PGEN) Posts Fourth Quarter Loss, Misses Revenue Expectations
101 finance2026-03-25 22:42:50

Precigen Jumps 28% During the Day: Is This a Biotech Rally or a Risky Move?
101 finance2026-03-26 14:48:58

Precigen's $430M Burn vs $18M Q1 Bet: Why Wall Street's $8.50 Target Risks a Reality Check
101 finance2026-03-27 00:30:53

Precigen’s Platform Gains Exponential Traction as Gene Therapy Adoption Infrastructure Takes Hold
101 finance2026-03-27 12:27:40

Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31
Finviz2026-03-30 12:33:38

Precigen Surges 11% in Dramatic Intraday Rally: What's Fueling the Momentum?
101 finance2026-03-31 16:34:17

Precigen Drops 8.19% as Market Sends Mixed Messages and Technical Indicators Turn Bearish
101 finance2026-04-01 00:18:46

Precigen’s PAPZIMEOS: S-Curve Uptake Accelerates as Barriers Diminish
101 finance2026-04-01 05:57:45

PGEN Soars 18% But Bearish Tech Signals Warn of Volatility
101 finance2026-04-02 00:43:13

Precigen's Revenue Beat Already Priced In, But Burn Rate Risks Remain Unseen
101 finance2026-04-06 02:54:54

Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million
Finviz2026-04-07 11:03:42
PGEN stock chart
PGEN stock detailsPGEN stock price change
On the last trading day, PGEN stock closed at 4.12 USD, with a price change of 0.00% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more